486 related articles for article (PubMed ID: 19397416)
1. Prevention of infectious diseases in older adults through immunization: the challenge of the senescent immune response.
McElhaney JE
Expert Rev Vaccines; 2009 May; 8(5):593-606. PubMed ID: 19397416
[TBL] [Abstract][Full Text] [Related]
2. Overcoming the challenges of immunosenescence in the prevention of acute respiratory illness in older people.
McElhaney JE
Conn Med; 2003 Sep; 67(8):469-74. PubMed ID: 14587126
[TBL] [Abstract][Full Text] [Related]
3. Influenza and pneumococcal immunization rates among a high-risk population.
Chan-Tack KM
South Med J; 2001 Mar; 94(3):323-4. PubMed ID: 11284519
[TBL] [Abstract][Full Text] [Related]
4. Immunizations in older adults.
High K
Clin Geriatr Med; 2007 Aug; 23(3):669-85, viii-ix. PubMed ID: 17631240
[TBL] [Abstract][Full Text] [Related]
5. Update on vaccine-preventable diseases: are adults in your community adequately protected?
Schaffner W
J Fam Pract; 2008 Apr; 57(4 Suppl):S1-11; quiz S12. PubMed ID: 18655764
[TBL] [Abstract][Full Text] [Related]
6. Vaccination and healthy aging.
Maggi S
Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):3-6. PubMed ID: 20192710
[TBL] [Abstract][Full Text] [Related]
7. Health maintenance issues of the elderly. Immunization.
Levitt A
Md Med J; 1989 Feb; 38(2):141-3. PubMed ID: 2915621
[TBL] [Abstract][Full Text] [Related]
8. Influenza control in the 21st century: Optimizing protection of older adults.
Monto AS; Ansaldi F; Aspinall R; McElhaney JE; Montaño LF; Nichol KL; Puig-Barberà J; Schmitt J; Stephenson I
Vaccine; 2009 Aug; 27(37):5043-53. PubMed ID: 19559118
[TBL] [Abstract][Full Text] [Related]
9. Improving immunogenicity and effectiveness of influenza vaccine in older adults.
Cao W; Kim JH; Chirkova T; Reber AJ; Biber R; Shay DK; Sambhara S
Expert Rev Vaccines; 2011 Nov; 10(11):1529-37. PubMed ID: 22043953
[TBL] [Abstract][Full Text] [Related]
10. Influenza, pneumonia, tetanus: how effective is vaccination?
Powers DC; Sears SD
Geriatrics; 1987 Oct; 42(10):81-2, 87-90. PubMed ID: 3653696
[TBL] [Abstract][Full Text] [Related]
11. The unmet need in the elderly: designing new influenza vaccines for older adults.
McElhaney JE
Vaccine; 2005 Jul; 23 Suppl 1():S10-25. PubMed ID: 15908062
[TBL] [Abstract][Full Text] [Related]
12. A dose-ranging study of a subunit Respiratory Syncytial Virus subtype A vaccine with and without aluminum phosphate adjuvantation in adults > or =65 years of age.
Langley JM; Sales V; McGeer A; Guasparini R; Predy G; Meekison W; Li M; Capellan J; Wang E
Vaccine; 2009 Sep; 27(42):5913-9. PubMed ID: 19651171
[TBL] [Abstract][Full Text] [Related]
13. Vaccines for persons at high risk, 2007.
Zimmerman RK; Middleton DB
J Fam Pract; 2007 Feb; 56(2 Suppl Vaccines):S38-46, C4-5. PubMed ID: 17270109
[TBL] [Abstract][Full Text] [Related]
14. Vaccine responsiveness in the elderly: best practice for the clinic.
Aspinall R; Lang PO
Expert Rev Vaccines; 2014 Jul; 13(7):885-94. PubMed ID: 24890875
[TBL] [Abstract][Full Text] [Related]
15. Plans feel pressure to vaccinate more adults. The cost-effectiveness of prevention is undeniable, yet vaccination rates for everything but influenza decline.
Sipkoff M
Manag Care; 2008 Aug; 17(8):32-4. PubMed ID: 18777787
[No Abstract] [Full Text] [Related]
16. Vaccination of adults with asthma and COPD.
Pesek R; Lockey R
Allergy; 2011 Jan; 66(1):25-31. PubMed ID: 20716316
[TBL] [Abstract][Full Text] [Related]
17. Vaccine effectiveness in older individuals: what has been learned from the influenza-vaccine experience.
Lang PO; Govind S; Mitchell WA; Siegrist CA; Aspinall R
Ageing Res Rev; 2011 Jul; 10(3):389-95. PubMed ID: 20888439
[TBL] [Abstract][Full Text] [Related]
18. Age-related decline in immunity: implications for vaccine responsiveness.
Kumar R; Burns EA
Expert Rev Vaccines; 2008 May; 7(4):467-79. PubMed ID: 18444893
[TBL] [Abstract][Full Text] [Related]
19. Preventing tetanus, influenza, and pneumococcal infection in adults.
Marion GS
Physician Assist; 1992 Oct; 16(10):27-8, 33-4, 36 passim. PubMed ID: 10136576
[TBL] [Abstract][Full Text] [Related]
20. Vaccines and immunotherapies for the prevention of infectious diseases having cutaneous manifestations.
Wu JJ; Huang DB; Pang KR; Tyring SK
J Am Acad Dermatol; 2004 Apr; 50(4):495-528; quiz 529-32. PubMed ID: 15034501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
